Fengycin Controls the Apple Blue Disease Caused by <i>Penicillium expansum</i>

Ruimin Fu,Feng Yu,Yulian Zhang,Wuling Chen
DOI: https://doi.org/10.17957/IJAB/15.1483
2020-01-01
Abstract:The fenC gene deletion mutant of Bacillus amyloliquefaciens BA-16-8 was constructed to investigate the function of fengycin in controlling apple blue mold disease. The upstream and the downstream sequences of the fenC gene were cloned through PCR by using the genome of B. amyloliquefaciens BA-16-8 as a template in accordance with the homologous recombination principle. The recombinant plasmid pMAD-Delta fen was constructed by connecting the upstream and the downstream homologous regions of fenC with the spectinomycin resistance gene spc and then transformed into B. amyloliquefaciens through electroporation. The fenC knockout mutant strain BA-16-8-Delta fen was subcultured continuously at 42 degrees C and selected though blue-white colony screening, high-temperature screening, and antibiotic resistance tests. The inhibitory effect of the fengycin-deficient mutant BA-16-8-ifen on apple blue mold disease was tested via high-performance liquid chromatography, mass spectrometry, and Penicillium expansum growth inhibition assay in vitro. Compared with the wild-type B.amyloliquefaciens BA-16-8 strain, the B. amyloliquefaciens BA-16-8-Delta fen mutant lost its fengycin-synthesizing capability and showed a significantly reduced inhibitory effect against P. expansum. This study concludes that Fengycin is the key component of B. amyloliquefaciensBA-16-8 in the control of blue mold disease. (C) 2020 Friends Science Publishers
What problem does this paper attempt to address?